As a result, 35 employees were laid off, which followed two other layoff rounds to help ... Williams served as Five Prime Therapeutics' CEO for more than 15 years before its acquisition by Amgen.
April 4 (Reuters) - Boehringer Ingelheim on Thursday said it will lay off some of its salesforce due ... with the same prices as Boehringer and Amgen, whose Amjevita was the first Humira ...
In recent years, Amgen has been using acquisitions as a way to bolster its competitive position. And that's the big unknown for investors going forward: whether its recent purchases will pay off.
Just last week, Tesla laid off yet another round of workers. This time, however, Tesla gutted an entire team. Around 500 ...
Some experts say the recommended doses for drugs like sotorasib are too high, and they are advocating for a change in how cancer drugs are dosed. They want to do away with the concept of the maximum ...
Amgen and Johnson & Johnson earned billions on the trio of anemia drugs Epogen, Procrit and Aranesp since their introduction in 1989. But over time, an understanding of their risks has grown, as ...
Researchers including the team at Columbia and drugmakers are trying to solve the biggest problem in the weight-loss industry ...
The move comes after the Elon Musk-led automaker disbanded its EV charging department following Tesla’s announcement last ...
As with Epogen, the initial discoveries that laid the basis for the drug had ... That decade of investment and research was paying off. In 1992, Amgen hit the billion dollars sales mark and ...
Amgen's acquisition of Horizon Therapeutics has made it a major player in the rare disease space, with potential for long-term shareholder return. The company has key pipeline milestones in 2024 ...
(Adds Boehringer comment in paragraphs 4 and 5 of April 4 story) By Patrick Wingrove April 5 (Reuters) - Boehringer Ingelheim on Thursday said it will lay off some of its U.S. salesforce due to ...